在长期抗病毒治疗后,HBV整合对肝细胞癌的影响
Hang Wang1, Bobin Hu1, Hengkai Liang1
1Department of Infectious Diseases, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530021, People's Republic of China.
International journal of general medicine
|June 11, 2024
概括
剩余的乙型肝炎病毒 (HBV) 整合加速肝细胞癌 (HCC) 的发展,影响患者的治疗结果. 这些HBV整合事件导致基因组不稳定性和新型融合基因,这对于HBV-HCC检测至关重要.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 基因组学就是基因组学.
- 在瘤学瘤学.
背景情况:
- 肝细胞癌 (HCC) 是一个主要的全球健康问题,通常与慢性乙型肝炎病毒 (HBV) 感染有关.
- 长期的抗病毒疗法旨在控制HBV复制,但其对HBV整合在HCC中的影响仍然不完全理解.
研究的目的:
- 在长期抗病毒治疗后,研究HBV与HBV相关的HCC患者的HBV整合特征.
- 评估HBV整合对患者指标的临床影响.
- 分析HBV在HCC发育中的整合的潜在机制.
主要方法:
- 全基因组关联研究 (GWAS) 用于检测肝癌组织中的HBV集成.
- 根据HBV整合的存在,患者被分为整合 (Int) 和非整合 (N-int) 组.
- 监测了临床指标,并在染色体和基因组水平上分析了HBV整合模式.
主要成果:
- 尽管抗病毒治疗后HBV残留的整合频率降低,但加速HCC的进展,影响诊断,治疗和预后.
- 乙型肝炎病毒整合事件诱导染色体结构变化和与HCC相关的基因重组.
- 经常检测到新的融合基因,显示出HBV相关HCC的特定生物标志物的潜力.
结论:
- 乙型肝炎病毒整合事件与人类基因组和乙型肝炎病毒相互作用,导致基因组不稳定性和与HCC相关的基因重组.
- 特定的融合基因的形成为HBV-HCC提供了潜在的诊断标.
更多相关视频
相关概念视频
Retrovirus Life Cycles
45.8K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.8K
Mechanisms of Retrovirus-induced Cancers
5.1K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.1K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K


